InsiderTrades.com logo

James Marken Biography and Net Worth

Senior Vice President, Operations and Product Development of ANI Pharmaceuticals
  • LinkedIn
  • Phone
  • Email
  • Website


Mr. Marken has been the Company’s Senior Vice President, Operations since December 2021.  Mr. Marken joined ANI in May 2007 as General Manager of the Minnesota facilities and served as ANI’s Vice President, Operations from March 2009 unitl June 2016. Mr. Marken served as Senior Vice President, Operations and Product Development from June 2016 until December 2021, for both Minnesota facilities and the Oakville, ON facility, which was sold in March 2024.  Mr. Marken brings over 30 years of pharmaceutical industry experience to his position. Prior to joining ANI Pharmaceuticals, he worked for Solvay Pharmaceuticals in various departments including Quality Control, Validation and Manufacturing. Mr. Marken holds a B.S. in Chemistry from Bemidji State University.

What is James G. Marken's net worth?

The estimated net worth of James G. Marken is at least $8.42 million as of March 7th, 2024. Mr. Marken owns 124,492 shares of ANI Pharmaceuticals stock worth more than $8,416,904 as of March 30th. This net worth evaluation does not reflect any other investments that Mr. Marken may own. Additionally, Mr. Marken receives a salary of $673,230.00 as Senior Vice President, Operations and Product Development at ANI Pharmaceuticals. Learn More about James G. Marken's net worth.

How old is James G. Marken?

Mr. Marken is currently 61 years old. There are 8 older executives and no younger executives at ANI Pharmaceuticals. Learn More on James G. Marken's age.

What is James G. Marken's salary?

As the Senior Vice President, Operations and Product Development of ANI Pharmaceuticals, Inc., Mr. Marken earns $673,230.00 per year. There are 5 executives that earn more than Mr. Marken. The highest earning executive at ANI Pharmaceuticals is Mr. Nikhil Lalwani, President, CEO & Director, who commands a salary of $2,320,000.00 per year. Learn More on James G. Marken's salary.

How do I contact James G. Marken?

The corporate mailing address for Mr. Marken and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at ir@anipharmaceuticals.com. Learn More on James G. Marken's contact information.

Has James G. Marken been buying or selling shares of ANI Pharmaceuticals?

James G. Marken has not been actively trading shares of ANI Pharmaceuticals within the last three months. Most recently, James G. Marken sold 24,338 shares of the business's stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $66.37, for a transaction totalling $1,615,313.06. Following the completion of the sale, the senior vice president now directly owns 124,492 shares of the company's stock, valued at $8,262,534.04. Learn More on James G. Marken's trading history.

Who are ANI Pharmaceuticals' active insiders?

ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.

Are insiders buying or selling shares of ANI Pharmaceuticals?

During the last year, insiders at the specialty pharmaceutical company sold shares 33 times. They sold a total of 268,126 shares worth more than $16,946,714.15. The most recent insider tranaction occured on March, 13th when VP Meredith Cook sold 400 shares worth more than $25,332.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.

Information on this page was last updated on 3/13/2025.

James G. Marken Insider Trading History at ANI Pharmaceuticals

See Full Table

James G. Marken Buying and Selling Activity at ANI Pharmaceuticals

This chart shows James G Marken's buying and selling at ANI Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal Insider BuyingTotal Insider Selling

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals logo
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Read More

Today's Range

Now: $67.61
Low: $67.02
High: $68.49

50 Day Range

MA: $60.49
Low: $54.51
High: $68.36

2 Week Range

Now: $67.61
Low: $52.50
High: $70.00

Volume

355,964 shs

Average Volume

256,304 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63